Loading…
BlackRock Health Sciences Trust is projected to rise to $54.97 by 2027, a +28% move from its current price of $43.01. BME is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $42.68 | $43.03 | $43.38 | +0.04% |
| Jul 13 | $42.55 | $43.05 | $43.55 | +0.08% |
| Jul 14 | $42.46 | $43.06 | $43.68 | +0.13% |
| Jul 15 | $42.38 | $43.08 | $43.79 | +0.17% |
| Jul 16 | $42.32 | $43.10 | $43.89 | +0.21% |
| Jul 17 | $42.26 | $43.12 | $43.99 | +0.25% |
| Jul 18 | $42.21 | $43.14 | $44.08 | +0.29% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $42.21 | $43.14 | $44.08 | +0.29% |
| Week 2 | $41.96 | $43.26 | $44.60 | +0.59% |
| Week 3 | $41.80 | $43.39 | $45.04 | +0.88% |
| Week 4 | $41.68 | $43.52 | $45.44 | +1.18% |
| Week 5 | $41.59 | $43.64 | $45.80 | +1.47% |
| Week 6 | $41.52 | $43.77 | $46.15 | +1.77% |
| Week 7 | $41.46 | $43.90 | $46.48 | +2.07% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
BlackRock Health Sciences Trust (BME) is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC and invests in the public equity markets of the United States. It seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.
It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.
The BlackRock Health Sciences Trust is listed with a current price of $42.91, a market cap of $554.57M, and a rank of 2828. The current price sits within a forecast that projects a path of growth across the coming years, with the 2026 average at $42.91 and 2027 at $55.07. The longer-horizon forecast shows the average price rising to $71.60 by 2030, $193.95 by 2040, and $348.81 by 2050, with corresponding ROI figures of 66.9% by 2030, 352% by 2040, and 712.9% by 2050.
The outlook indicates a bullish long-term trajectory after a neutral start in 2026 and continuing bullish sentiment through 2050.
A major floor 13.3% below — a decisive break under it would weaken the trend.
The nearest floor, 8.8% below — buyers have tended to step in here.
Price is pressing into resistance (2.2% away) — a breakout level to watch.
A major ceiling 8.8% above — clearing it would confirm fresh momentum.
Key BME support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BME market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $43.50 | Sell | $43.30 | Sell |
| MA 10 | $43.25 | Sell | $42.96 | Buy |
| MA 20 | $41.86 | Buy | $42.17 | Buy |
| MA 50 | $40.42 | Buy | $41.04 | Buy |
| MA 100 | $40.27 | Buy | $40.52 | Buy |
| MA 200 | $40.14 | Buy | $40.00 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 64.32 | Neutral |
| Stoch RSI (14) | 49.14 | Neutral |
| CCI (20) | 55.31 | Neutral |
| Williams %R (14) | -23.28 | Info |
| MACD (12,26,9) | 0.11 | Buy |
| ROC (12) | 6.70 | Buy |
| Bollinger %B (20,2) | 0.70 | Neutral |
| Stochastic %K (14) | 76.72 | Neutral |
| TRIX (15) | 0.30 | Buy |
| Awesome (5,34) | 2.48 | Buy |
| Ultimate (7,14,28) | 61.51 | Neutral |
| Momentum (10) | 1.46 | Buy |
| Aroon Osc (25) | 88.00 | Buy |
| Hull MA (9) | 43.54 | Sell |
| ADX (14) | 31.77 | Buy |
| ATR (14) | 0.33 | Info |
The 30-day technical picture notes a bullish sentiment with RSI14 at 80 and price indicators above recent averages. The SMA50 is listed at $39.78 and the SMA200 at $39.87, with a nearby support at $38.63 and a resistance at $42.91. The 30-day price range lies between $40.46 (low) and $45.51 (high), reflecting near-term volatility around the current level.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $37.67 | $43.01 | $60.19 | 0% | Neutral | |
| $45.02 | $54.97 | $70.17 | +28% | Bullish | |
| $49.96 | $62.14 | $81.48 | +44% | Bullish | |
| $50.94 | $64.35 | $86.17 | +50% | Bullish | |
| $55.45 | $70.99 | $96.77 | +65% | Bullish | |
| $62.26 | $80.69 | $111.73 | +88% | Bullish | |
| $69.24 | $90.74 | $127.44 | +111% | Bullish | |
| $81.48 | $107.91 | $153.51 | +151% | Bullish | |
| $89.00 | $119.03 | $171.35 | +177% | Bullish | |
| $91.68 | $123.78 | $180.18 | +188% | Bullish | |
| $136.40 | $192.07 | $292.98 | +347% | Bullish | |
| $229.96 | $347.29 | $567.86 | +707% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $37.67 | $43.01 | $51.93 | +0.00% |
| August 2026 | $38.27 | $44.81 | $53.59 | +4.17% |
| September 2026 | $37.98 | $44.68 | $53.86 | -0.28% |
| October 2026 | $38.79 | $45.82 | $55.59 | +2.55% |
| November 2026 | $40.58 | $48.09 | $58.68 | +4.97% |
| December 2026 | $41.28 | $49.09 | $60.19 | +2.07% |
Click any year to see its month-by-month BME forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, BME could reach as high as $60.19, with a base case around $43.01 and support toward $37.67 — roughly 0% from $43.01. A consolidation phase looks the most probable path here.
Expect BME to range from $45.02 to $70.17 through 2027. The $54.97 average target implies a +28% move from current prices. That is up +28% on the projected 2026 average. Momentum favours further upside here.
The BME price prediction for 2028 points to an average of $62.14 (low $49.96, high $81.48) — a potential gain of +44% on today's $43.01. Buyers look set to stay in control over this stretch.
In 2029, BME is projected to trade between $50.94 and $86.17, averaging $64.35 — a potential gain of +50% from today's $43.01. That is up +4% on the projected 2028 average. Momentum favours further upside here.
BlackRock Health Sciences Trust's 2030 outlook centres on $70.99, within a $55.45 to $96.77 range. That is up +10% on the projected 2029 average. That marks a +65% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, BME could reach as high as $111.73, with a base case around $80.69 and support toward $62.26 — roughly +88% from $43.01. Momentum favours further upside here.
Expect BME to range from $69.24 to $127.44 through 2032. The $90.74 average target implies a +111% move from current prices. That is up +12% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The BME price prediction for 2033 points to an average of $107.91 (low $81.48, high $153.51) — a potential gain of +151% on today's $43.01. Momentum favours further upside here.
In 2034, BME is projected to trade between $89.00 and $171.35, averaging $119.03 — a potential gain of +177% from today's $43.01. That is up +10% on the projected 2033 average. Buyers look set to stay in control over this stretch.
BlackRock Health Sciences Trust's 2035 outlook centres on $123.78, within a $91.68 to $180.18 range. That is up +4% on the projected 2034 average. That marks a +188% change versus current levels. Momentum favours further upside here.
By 2040, BME could reach as high as $292.98, with a base case around $192.07 and support toward $136.40 — roughly +347% from $43.01. Buyers look set to stay in control over this stretch.
Expect BME to range from $229.96 to $567.86 through 2050. The $347.29 average target implies a +707% move from current prices. That is up +81% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in BME today (≈ 23.250407 BME) could be worth
$8,074.65
+$7,074.65 (+707%) by 2050 · US Dollar
Based on the average projected BME price of $347.29 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BMEwould be worth at today's price.
$1,000 invested in BME on Jul 10, 2025 (≈ 27.18869 BME) would be worth
$1,169.39
+$169.39 (+16.9%) today · 1.17× · US Dollar
Based on a BME entry price of $36.78 vs. today's $43.01.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $43.65 | $985.34 | -1.5% |
| 1 month ago | $40.31 | $1,066.98 | +6.7% |
| 3 months ago | $39.28 | $1,094.96 | +9.5% |
| 6 months ago | $41.89 | $1,026.74 | +2.7% |
| 1 year ago | $36.78 | $1,169.39 | +16.9% |
| All time (5.0y) ago | $49.33 | $871.88 | -12.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BME forecast.
Our base-case forecast reaches $86.00 around 2032.
Implied market cap at $86.00: $1.11B
Looking across the multi-year forecast, the average price rises from $42.91 in 2026 to $71.60 in 2030, then to $193.95 in 2040 and $348.81 in 2050. The associated ROI figures move from 0% in 2026 to 66.9% in 2030, 352% in 2040, and 712.9% in 2050, with bullish sentiment assigned for 2027 and beyond. The 2031–2035 forecast years show continued gains in the average price and higher ROI, culminating in very strong upside by 2050, though these are estimates and not guarantees.
The forecast reflects a continued bullish trajectory over the horizon.
Tap a question to reveal the answer.
The 2030 forecast shows an avg price of $71.60, with a min of $55.91 and a max of $97.66. The ROI is projected at 66.9% and the sentiment is BULLISH.
The forecast indicates a bullish trajectory from 2027 onward, with rising average prices and positive ROI through 2030, 2040, and 2050, though these are estimates and not guarantees.
Yes, the 2031 forecast lists a max of $112.98, suggesting that reaching $100 is within the 2031 maximum according to the forecast.
The 2040 forecast shows an avg price of $193.95, with a min of $137.70 and a max of $295.92. The ROI is projected at 352, with sentiment BULLISH.
The 2050 forecast shows an avg price of $348.81, with a min of $230.92 and a max of $570.45. The ROI is projected at 712.9, with sentiment BULLISH.
BlackRock Health Sciences Trust Community Discussion
0Share your BlackRock Health Sciences Trust price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.